Apyx Medical (APYX) Change in Cash (2011 - 2026)

Apyx Medical (APYX) has reported Change in Cash for 16 consecutive years, with -$3.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Cash fell 105.85% year-over-year to -$3.5 million; the trailing twelve-month figure through Jun 2026 stood at -$1.7 million (up 50.13% YoY), and the FY2025 full-year result was -$1000.0, up 99.99% from the prior year.
• Change in Cash declined to -$3.5 million in Q2 2026 per APYX's latest filing, from -$603000.0 in the prior quarter.
• Across five years, Change in Cash topped out at $21.5 million in Q4 2023 and bottomed at -$6.4 million in Q1 2024.
• Historically, Change in Cash has averaged -$180722.2 across 5 years, with a median of -$2.6 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Change in Cash slumped 16475.0% in 2022, then surged 563.65% in 2023.
• Over 5 years, Change in Cash stood at -$4.6 million in 2022, then soared by 563.65% to $21.5 million in 2023, then plunged by 82.67% to $3.7 million in 2024, then surged by 77.17% to $6.6 million in 2025, then slumped by 153.29% to -$3.5 million in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered -$3.5 million, -$603000.0, and $6.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.